The Parkinson's drug Comtam for obesity and diabetes

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Obesity; diabetes

In silico and mouse studies identified Comtan entacapone as an FTO inhibitor that could help treat obesity and

Read the full 220 word article

How to gain access

Continue reading with a
two-week free trial.